Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,947 total articles
MiNK Therapeutics reported Q1 2026 financial results and highlighted progress on its off-the-shelf invariant natural killer T cell therapy, agenT-797, which has entered a randomized Phase 2 trial targeting severe acute lung injury and critical illness. The trial aims to address a significant unmet need in acute respiratory distress syndrome (ARDS),…
RenX Enterprises Corp. announced its Q1 2026 results, showcasing a 20.5% quarter-over-quarter revenue increase to $3.96 million. The Logistics segment achieved positive operating and net income, while the Biomass Recycling segment saw a 44% increase in material sales and introduced a new land-clearing service. The upgraded Myakka City processing pl…
Palvella Therapeutics announced promising data from its Phase 2 TOIVA trial evaluating QTORIN™ rapamycin for cutaneous venous malformations. The trial showed statistically significant improvements in bleeding and patient satisfaction after 12 weeks of treatment, highlighting QTORIN's potential to become the first FDA-approved therapy for this rare …
Edible Garden AG reported strong first quarter 2026 results with a 22.9% revenue increase driven by broad growth in cut herbs, vitamins, supplements, and branded condiments. The company is advancing its strategic evolution into a clean-label consumer packaged goods and ready-to-drink (RTD) nutrition platform, highlighted by expansion into over 6,00…
Profusa, Inc., a digital health company specializing in tissue-integrated biosensors, announced it has transferred its stock listing to the Nasdaq Capital Market effective May 15, 2026. This move aligns with previously disclosed plans to meet Nasdaq's bid price and stockholders' equity requirements to maintain compliance and listing status. Profusa…
Super League Enterprise, Inc. announced Q1 2026 financial results showing gross revenue growth from $2.7 million to $3.0 million year-over-year and an improvement in gross margin from 32% to 36%. The company's cash-based EBITDA improved 11% year-over-year, and it ended the quarter with $11.4 million in cash and investments. The recent acquisition o…
SOLOWIN HOLDINGS (NASDAQ: AXG), through its stablecoin issuer AX Coin, has signed a non-binding MOU with Gulf-based fintech INFINIOS to collaborate on regulated wallet infrastructure and digital payment solutions to accelerate stablecoin adoption. The partnership will integrate AX Coin into INFINIOS' payments infrastructure, enabling custodial and …
JOYY Inc., a global technology company listed on NASDAQ, announced it will release its first quarter 2026 financial results on May 25, 2026, followed by a management earnings conference call. The event will include a webcast and telephonic replay options for investors and stakeholders.
PMGC Holdings Inc. reported strong Q1 2026 results with total assets exceeding $26 million, a 102% increase from year-end 2025. Revenue for the quarter was approximately $682,000, surpassing the full-year 2025 revenue in a single quarter, fueled by recent acquisitions including SVM Machining and A&B Aerospace. The company also formed NorthStrive De…
Instil Bio, a Nasdaq-listed biotech company, announced its Q1 2026 financial results showing a significant reduction in net loss compared to the previous year, a stable cash position expected to fund operations beyond 2027, and an ongoing strategic evaluation of acquisitions and in-licensing opportunities to expand its therapeutic pipeline.
Kymera Therapeutics presented new clinical data at the SID and ATS meetings demonstrating that KT-621, a first-in-class oral STAT6 degrader, shows robust target engagement, reduction of Type 2 inflammatory biomarkers, and initial clinical activity in atopic dermatitis and asthma. Phase 2b trials are ongoing with data expected by mid and late 2027, …
CECO Environmental Corp. and Thermon Group Holdings, Inc. announced that Thermon stockholders must elect their preferred form of merger consideration by May 22, 2026, ahead of the expected closing of CECO's acquisition of Thermon on June 1, 2026. Thermon shareholders can choose from stock, a combination of stock and cash, or cash consideration. The…
Nutriband Inc. and its subsidiary Active Intelligence will showcase an expanding portfolio of AI-driven wellness and recovery products, including new launches like AI Performance Tape, AI Energy Patches, and AI Sleep solutions, at the upcoming ECRM conference in June 2026. The company plans meetings with major retailers such as Walmart, Walgreens, …
Traws Pharma, a clinical-stage biopharmaceutical company, announced a private financing deal raising up to $60 million to support operations through Q1 2027, while advancing its lead antiviral candidate tivoxavir marboxil (TXM) into a human influenza challenge trial. The company is also developing a potential therapy for hantavirus infections. Q1 f…
BioXcel Therapeutics announced FDA acceptance of its supplemental New Drug Application (sNDA) for IGALMI® to be used in an at-home setting for acute agitation in bipolar disorder and schizophrenia, with a PDUFA date set for November 14, 2026. The company is advancing late-stage clinical trials for BXCL501 in agitation associated with Alzheimer's de…
Satellos Bioscience reported Q1 2026 financial results highlighting significant progress in its clinical-stage biotechnology programs targeting Duchenne muscular dystrophy (DMD). The company successfully raised $57 million, extending its cash runway into 2027, uplisted to Nasdaq, and advanced enrollment and dosing in its Phase 2 BASECAMP pediatric …
CCC Intelligent Solutions Holdings Inc., a leading SaaS and AI platform provider for the insurance economy, announced its management team will present at the J.P. Morgan 2026 Global Technology, Media and Communications Conference. The presentation will be webcast live and replayed on the investor relations website.
Indaptus Therapeutics reported a net loss of $2.5 million for Q1 2026, marking an improvement compared to the previous year. The company is undergoing executive management changes and is reassessing its development priorities, particularly its Decoy platform. Operational expenses have decreased, but cash reserves have significantly diminished, prom…
Aurora Mobile Limited's AI-native platform GPTBots.ai, integrated with its EngageLab LiveDesk service, enabled Axios Management Inc. to provide seamless, round-the-clock real estate consultation for international clients. This solution overcame time zone challenges, increased conversion rates, and delivered a 37.5% ROI within the first week, demons…
Purple Biotech Ltd. reported its Q1 2026 financial results, highlighted by promising new patient-derived tumor data supporting their lead tri-specific antibody candidate IM1240, demonstrating anti-tumor activity in treatment-resistant cancers. The company formed a Scientific Advisory Board and expanded its collaboration with Converge Bio to leverag…
Quantum Cyber N.V. (Nasdaq: QUCY) announced the launch of its new website quantum-cyber.ai, showcasing its AI-powered, quantum-accelerated System-of-Systems autonomous defense platform. The platform includes drone warfare, counter-UAS, EMP shielding, autonomous demining, and quantum antenna technologies. The launch aligns with increased U.S. govern…
Genco Shipping & Trading Limited's Board unanimously rejected a $23.50 per share unsolicited tender offer from Diana Shipping Inc., stating the offer undervalues Genco's assets and business and lacks a control premium. The Board recommends shareholders not tender their shares and vote for Genco’s current directors, emphasizing Genco's strong standa…
New Era Energy & Digital announced the filing of its Q1 2026 Form 10-Q, highlighting strategic progress in its next-generation digital infrastructure business, centered on the Texas Critical Data Centers campus. Key achievements include land acquisition to expand its data center corridor, partnership agreements to support development and financing,…
Telix Pharmaceuticals has entered letters of intent to collaborate with EDAP TMS and Profound Medical, leaders in minimally invasive and image-guided ablative technologies for prostate cancer. The partnerships aim to explore the use of Telix's PSMA-PET imaging agents to support patient selection, treatment planning, and monitoring in emerging prost…
Clearway Energy, Inc. announced that Kevin P. Malcarney will retire as Executive Vice President, General Counsel, and Corporate Secretary effective June 1, 2026. Michael A. Brown, a former Clearway executive with legal experience at The New York Times and NRG Yield, will succeed him. The transition aims to ensure continuity and leverage Brown's dee…
